跳至主要内容
临床试验/NCT02179996
NCT02179996Unknown4 期

Comparison of Two Vaccinal Schemes for DTP-Pertussis-Hib Primo-immunisation in Very Preterm-born Neonates: a Randomised Bicentric Controlled Study

Central Hospital, Nancy, France4 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2014年1月1日最近更新:
适应症

试验速览

阶段
4 期
发起方
入组人数
160
试验地点
4
主要终点
Hib antibody dosage in blood sample

研究概览

简要总结

Preterm neonates are fragile to infections. Their immune system is immature, yet in France, primary vaccines are injected at two months of age, as in term infants.

Recommendations for vaccinations in infants have changed in France in 2013, suppressing the second injection at three months after birth. Preterm and full-term born infants are now vaccinated at two and four months of age, but no data regarding efficacy in very preterm infants have been registered.

The investigators hypothesize that two vaccine injections (at two and four months) would be less efficient than three injections (two, three and four months) in very preterm-born infants.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
— 至 6 Months(Child)
性别
All
接受健康志愿者

入选标准

  • infants born < 33 weeks gestation in Nancy and Thionville Maternity Wards
  • signed parental consent

排除标准

  • immunodeficiency
  • vaccine contra-indication

结局指标

主要结局

Hib antibody dosage in blood sample

时间窗: 5 months after birth

次要结局

  • Pertussis antibody dosage in blood sample(5 months after birth)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Principal Investigator
主要研究者

Pr Rachel VIEUX

Professor Rachel Vieux

Central Hospital, Nancy, France

研究点 (4)

Loading locations...

相似试验